| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 372 | 0 | 2.317 | 82.831 | 12.155 | 4.061 | 27.980 | 208.357 |
| Total Income - EUR | - | - | 372 | 84 | 2.317 | 82.831 | 12.155 | 4.061 | 28.008 | 208.358 |
| Total Expenses - EUR | - | - | 136 | 57 | 63 | 60.489 | 11.322 | 2.740 | 26.944 | 204.503 |
| Gross Profit/Loss - EUR | - | - | 236 | 27 | 2.254 | 22.342 | 833 | 1.321 | 1.064 | 3.855 |
| Net Profit/Loss - EUR | - | - | 198 | 25 | 2.185 | 21.604 | 476 | 1.208 | 863 | 3.096 |
| Employees | - | - | 0 | 0 | 0 | 2 | 2 | 0 | 1 | 1 |
Check the financial reports for the company - Servoclin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 50.435 | 87.873 |
| Current Assets | - | - | 290 | 273 | 2.543 | 120.879 | 57.482 | 88.140 | 89.666 | 96.083 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 15.289 | 47.089 | 26.432 | 9.122 |
| Receivables | - | - | 0 | 0 | 0 | 9.923 | 24.750 | 33.283 | 59.627 | 80.361 |
| Cash | - | - | 290 | 273 | 2.543 | 110.956 | 17.444 | 7.768 | 3.607 | 6.599 |
| Shareholders Funds | - | - | 242 | 262 | 2.442 | 79.916 | 32.293 | 33.601 | 34.362 | 37.266 |
| Social Capital | - | - | 44 | 43 | 42 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | - | 49 | 11 | 101 | 40.963 | 25.189 | 54.539 | 105.739 | 146.689 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4312 - 4312" | |||||||||
| CAEN Financial Year |
4312
|
|||||||||
Comments - Servoclin Srl